Price alert —
Sign in to get a one-time email the moment CVS crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · CVS
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100.4B | $2.9B | $4.7B | $3.4B | 2.9% | 4.7% |
| 2025-12-31 | $105.7B | $2.9B | $2.1B | $2.6B | 2.8% | 2.0% |
| 2025-09-30 | $102.9B | $-4.0B | $2.5B | $0.1B | -3.9% | 2.4% |
| 2025-06-30 | $98.9B | $1.0B | $2.4B | $1.3B | 1.0% | 2.4% |
| 2025-03-31 | $94.6B | $1.8B | $3.4B | $3.8B | 1.9% | 3.6% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare CVS vs peers
Line CVS up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with CVS
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 20 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-06 | 2.57 | 2.21 | +16.5% | +0.6% |
| 2026-02-10 | 1.09 | 1.00 | +9.4% | +1.7% |
| 2025-10-29 | 1.60 | 1.36 | +17.9% | -4.8% |
| 2025-07-31 | 1.81 | 1.46 | +23.9% | +0.6% |
| 2025-05-01 | 2.25 | 1.67 | +34.5% | -2.9% |
| 2025-02-12 | 1.19 | 0.92 | +29.6% | +5.0% |
| 2024-11-06 | 1.09 | 1.46 | -25.2% | -7.4% |
| 2024-08-07 | 1.83 | 1.73 | +6.0% | +2.4% |
| 2024-05-01 | 1.31 | 1.70 | -22.8% | -2.1% |
| 2024-02-07 | 2.12 | 1.99 | +6.6% | -1.3% |
| 2023-11-01 | 2.21 | 2.13 | +3.7% | +1.3% |
| 2023-08-02 | 2.21 | 2.12 | +4.2% | -2.7% |
| 2023-05-03 | 2.20 | 2.09 | +5.2% | -1.8% |
| 2023-02-08 | 1.99 | 1.93 | +3.1% | +1.2% |
| 2022-11-02 | 2.15 | 1.99 | +7.9% | +1.0% |
| 2022-08-03 | 2.40 | 2.18 | +10.1% | +0.5% |
| 2022-05-04 | 2.22 | 2.15 | +3.5% | -2.8% |
| 2022-02-09 | 1.98 | 1.88 | +5.4% | +0.5% |
| 2021-11-03 | 1.97 | 1.79 | +10.3% | -1.9% |
| 2021-08-04 | 2.42 | 2.07 | +17.1% | -1.8% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS ★ | $137B | 47.1 | 12.8 | 0.3 | 13.2 | 1.8 | 13.4% | 6.1% | 63.1% | 3.79% |
| LLY | — | 41.8 | 26.3 | — | 30.1 | — | 82.8% | 55.5% | 169.9% | — |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | — | 36.0 | 13.2 | — | 12.1 | 6.9 | 76.7% | 4.9% | — | — |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | — | 19.1 | 8.8 | — | 7.6 | — | 74.8% | 5.4% | -10.1% | — |
| TMO | — | 29.2 | 19.5 | — | 21.1 | — | 40.9% | 6.2% | 11.3% | — |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 42.19%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 125,919,853 | 9.87% |
| Vanguard Capital Management LLC | 82,650,076 | 6.48% |
| Capital World Investors | 77,248,642 | 6.05% |
| State Street Corporation | 59,322,181 | 4.65% |
| Dodge & Cox Inc. | 51,780,116 | 4.06% |
| FMR, LLC | 31,196,890 | 2.45% |
| JPMORGAN CHASE & CO | 29,527,125 | 2.31% |
| Geode Capital Management, LLC | 29,459,042 | 2.31% |
| Vanguard Portfolio Management LLC | 25,997,348 | 2.04% |
| Invesco Ltd. | 25,138,946 | 1.97% |
Insider activity · 90d
3 buys / 10 sells · ratio 0.3 · Finnhub
- Newman Brian F 3,008 @ $90.98
- Compton-Phillips Amy F 9,557 @ $90.98
- AGUIRRE FERNANDO SELL 10,513 @ $93.50
- ROBBINS LARRY SELL 0 @ $93.31
- ROBBINS LARRY SELL 4,824,799 @ $93.45
- AGUIRRE FERNANDO SELL 12,076 @ $93.78
- ROBBINS LARRY SELL 5,195,261 @ $96.28
- ROBBINS LARRY SELL 5,196,061 @ $95.67
- ROBBINS LARRY SELL 5,262,942 @ $94.81
- ROBBINS LARRY SELL 5,415,633 @ $93.48
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-29 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-01 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-22 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-18 | 8-K | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-15 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-11 | PRIMARY DOCUMENT | view · |
| 13F-HR | 2026-05-07 | Institutional holdings (13F) | view · |
| 10-Q | 2026-05-06 | 10-Q | view · |
| 8-K | 2026-05-06 | 8-K | view · |
| DEF 14A | 2026-04-03 | DEFINITIVE PROXY STATEMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-20 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-03-19 | 8-K | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-02 | PRIMARY DOCUMENT | view · |
| 13F-HR | 2026-02-13 | Institutional holdings (13F) | view · |
| 10-K | 2026-02-10 | 10-K | view · |
| 8-K | 2026-02-10 | 8-K | view · |
| 4 | 2026-01-27 | PRIMARY DOCUMENT | view · |
| 4 | 2026-01-05 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-12-09 | 8-K | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-02 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-21 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-11-20 | 8-K | view · |
| 13F-HR | 2025-10-31 | Institutional holdings (13F) | view · |
| 10-Q | 2025-10-29 | 10-Q | view · |
About CVS
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The P…
Options picks · CVS
ITM + OTM ideas from the latest scanLoading…
Congress trades · CVS
STOCK Act disclosuresLoading…
SEC filings & insiders · CVS
EDGAR · liveLoading…
Holders · CVS
Institutions & insider activityLoading…